share_log

通化金马(000766.SZ):琥珀八氢氨吖啶片将向CDE提交新药上市申请

Tonghua Golden-horse Pharmaceutical Industry Co., Ltd. (000766.SZ): Amber Octahydroaminoacridine Tablets will submit a new drug application to the Center for Drug Evaluation.

Gelonghui Finance ·  Jul 2 03:30

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) stated on its investor interaction platform on July 2nd that the new drug Amber Octahydroaminoisquinoline Tablets has completed unblinding, statistical analysis report, clinical trial summary report, and the next step is to submit a new drug application for marketing to the Center for Drug Evaluation (CDE). Currently, the company is progressing normally according to the established work plan in accordance with relevant requirements of CDE.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment